Neutrophil-lymphocyte ratio, albumin-alkaline phosphatase ratio, and bilirubin predict outcomes in hepatectomy hepatolithiasis patients

Table 1 Comparison of general data between the groups, n (%)

Items	Good prognosis group (n = 94)	Poor prognosis group (n = 41)	t/χ2	P value
Sex			0.027	0.870
Male	45 (47.87)	19 (46.34)
Female	49 (52.13)	22 (53.66)
Age (years), mean ± SD	44.53 ± 5.27	44.83 ± 5.45	0.298	0.766
BMI (kg/m2), mean ± SD	21.46 ± 2.22	21.74 ± 2.16	0.678	0.499
Course of disease (years), mean ± SD	2.45 ± 0.50	2.39 ± 0.49	0.607	0.545
ASA score grade II	4 (4.26)	7 (17.07)	6.267	0.012
Partial hepatectomy	48 (51.06)	20 (48.78)	0.060	0.807
Anatomical hepatectomy	56 (59.57)	17 (41.46)	3.771	0.005
Location of hepatectomy			0.279	0.870
Bilateral hepatic lobectomy	29 (30.85)	13 (31.71)
Left hepatic lobectomy	31 (32.98)	15 (36.59)
Right hepatic lobectomy	34 (36.17)	13 (31.71)
Intraoperative blood loss (mL), mean ± SD	297.66 ± 26.74	386.93 ± 38.72	15.467	< 0.001
Intraoperative blood infusion	10 (10.64)	13 (31.71)	8.966	0.003
Hepatobiliary surgery history			4.844	0.028
Yes	38 (40.43)	25 (60.98)
No	56 (59.57)	16 (39.02)
Comorbidity
Hypertension	18 (19.15)	9 (21.95)	0.140	0.708
Hyperlipidemia	15 (15.96)	7 (17.07)	0.026	0.872
Diabetes	13 (13.83)	6 (14.63)	0.015	0.902

BMI: Body mass index; ASA: American Society of Anesthesiologists.